Welcome to our dedicated page for Willis Towers SEC filings (Ticker: WTW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Willis Towers Watson Public Limited Company (WTW) provides access to the company’s U.S. regulatory disclosures as an issuer with ordinary shares listed on the NASDAQ Global Select Market under the symbol WTW. As an Irish public limited company in the finance and insurance sector, WTW uses SEC filings to report material events, financial results and financing arrangements.
WTW files Form 8-K current reports for a range of topics. Recent filings include 8-Ks announcing quarterly financial results, an 8-K and 8-K/A related to an earnings release correction, an 8-K describing the entry into a Third Amended and Restated Credit Agreement establishing a revolving credit facility, and an 8-K detailing the pricing of senior unsecured notes issued by Willis North America Inc. and fully and unconditionally guaranteed by WTW and certain subsidiaries.
Through its registration statement on Form S-3 and related prospectus supplements, WTW discloses information about public offerings of debt securities, including the intended use of proceeds for permitted acquisitions, repayment of existing notes and other corporate purposes. These filings help investors understand WTW’s capital structure, liquidity resources and approach to financing transactions such as the proposed acquisition of Newfront.
On Stock Titan, this page surfaces WTW’s SEC filings with real-time updates from EDGAR and AI-powered summaries that explain the significance of each document in clear language. Users can quickly see which filings relate to earnings announcements, credit facilities, securities offerings or other material events, and can drill into the full text when deeper review is needed. Over time, investors can use these filings, alongside WTW’s broader disclosures about its Health, Wealth & Career and Risk & Broking segments, to track how advisory, broking and technology initiatives are reflected in the company’s regulatory reporting.
Willis Towers Watson Public Limited Company is asking shareholders to vote on six proposals at its 2026 Annual General Meeting. Items include electing nine directors, advisory approval of named executive officer pay, and ratifying Deloitte entities as U.S. and Irish auditors while fixing their remuneration.
Shareholders are also asked to renew the Board’s authority under Irish law to issue and to issue free of pre-emptive rights up to approximately 20% of issued ordinary share capital for 18 months, and to approve an amended Employee Share Purchase Plan that increases shares authorized for issuance by 3,122,500. The proxy highlights extensive board refreshment, new risk and operational oversight structures, strong say‑on‑pay support, and a pay-for-performance program where 2025 short-term incentives paid at 99.3%–131.1% of target and 2023 performance share units vested at 195.1% of target.
Willis Towers Watson PLC — The Vanguard Group filed Amendment No. 10 to a Schedule 13G/A reporting 0 shares beneficially owned of Willis Towers Watson common stock, representing 0% of the class. The amendment explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 resulting in disaggregated reporting by Vanguard subsidiaries and business divisions.
Willis Towers Watson plc General Counsel Matthew Furman reported mixed insider activity in company equity. On March 3, 2026, he acquired 27.2411 restricted share units at a stated price of $0.0000 per unit, bringing his total restricted share units to 2,587.9376.
On the same date, he sold 3,000 ordinary shares at a weighted average price of $304.0029 per share, with individual trades ranging from $303.82 to $304.25, and held 38,185.0596 ordinary shares afterward. The filing notes these restricted share units relate to the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees, which settles vested units into ordinary shares on a 1:1 basis upon specified separation or death timing conditions.
Willis Towers Watson plc reported that officer Imran Ahmed Qureshi, Global Head of Geographies, acquired 33.7597 restricted share units on March 3, 2026 as a grant or award. These units are credited under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and settle into Ordinary Shares on a 1:1 basis under the plan’s terms. Following this award, Qureshi held a total of 1,682.7248 restricted share units with direct ownership.
Willis Towers Watson PLC reported that officer Anne Pullum, Co-Head of Corporate Development, acquired 8.6461 restricted share units on March 3, 2026. The transaction is coded as a grant, award, or other acquisition of derivative securities.
The restricted share units are credited under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and, once vested, settle into ordinary shares with a nominal value of $0.000304635 per share on a 1:1 basis, following specific separation-from-service or death timing conditions. After this grant, Pullum directly held 917.8809 restricted share units under the plan.
Willis Towers Watson PLC reported that its PAO and Controller, Joseph Stephen Kurpis, acquired 6.6046 restricted share units on March 3, 2026 as a grant or award. These units are credited under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.
After this transaction, Kurpis held a total of 446.9538 restricted share units directly. According to the plan, vested units settle into ordinary shares on a 1:1 basis after separation from service or death, based on specified timing conditions.
Krasner Andrew Jay reported acquisition or exercise transactions in this Form 4 filing.
Willis Towers Watson plc Chief Financial Officer Andrew Jay Krasner reported receiving a grant of 22.1873 restricted share units under a non-qualified excess plan. After this award, he holds a total of 746.3968 restricted share units that will settle into ordinary shares on a 1:1 basis under the plan’s distribution rules.
WILLIS TOWERS WATSON PLC Chief Executive Officer Carl Aaron Hess reported an acquisition of 101.9769 restricted share units on March 3, 2026. These units are credited under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.
After this grant, Hess held a total of 8,393.0225 restricted share units directly. According to the plan, vested units settle into Ordinary Shares with a nominal value of $0.000304635 per share on a 1:1 basis, generally after separation from service or death, subject to the timing rules described.
Willis Towers Watson PLC reported that officer Julie Jarecke Gebauer, President of Health, Wealth & Career, acquired 81.6596 restricted share units on March 3, 2026 as a grant or award. Following this transaction, she held 5,574.2940 restricted share units directly.
According to the company’s Non-Qualified Stable Value Excess Plan for U.S. Employees, vested restricted share units settle into ordinary shares on a 1:1 basis. Settlement occurs on the first business day of an eligible month after separation from service or after the participant’s death, based on the plan’s specified timing rules.